PDCD1 and neoplasm: Dual blockade of TIGIT and PD-1 in melanoma patients synergistically increased the proliferation, degranulation, and cytokine secretion of tumor-infiltrating and tumor antigen-specific CD8+ T cells, demonstrating a potential for dual blockage (175).